Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Gilead Sciences
University of Washington
Mayo Clinic
Acerta Pharma BV
Dana-Farber Cancer Institute
Roswell Park Cancer Institute
City of Hope Medical Center
Janssen Pharmaceutical K.K.
University College, London
BeiGene
Mayo Clinic
Weill Medical College of Cornell University
University of Nebraska
TG Therapeutics, Inc.
Abramson Cancer Center at Penn Medicine
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Mayo Clinic
Dana-Farber Cancer Institute
Hackensack Meridian Health
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
Eli Lilly and Company
Dana-Farber Cancer Institute
Gilead Sciences
Pharmacyclics LLC.
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
University of Washington
Fred Hutchinson Cancer Center
University of Arizona
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Roswell Park Cancer Institute
University of Chicago
Gilead Sciences
Fred Hutchinson Cancer Center
Mayo Clinic
Barbara Ann Karmanos Cancer Institute
Yale University
Case Comprehensive Cancer Center
Dana-Farber Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dana-Farber Cancer Institute
Wake Forest University Health Sciences
National Cancer Institute (NCI)